This inverse correlation with clinical risk was confirmed by the fact that 84% of HR B-ALL cases showed low expression of ERG, as we report in Table 1, which depicts the CK2, MYC and ERG expression according to the Final risk group in children with T- and B-ALL. The gene discussed is MYC; the disease is acute lymphoblastic leukemia.